In activated B lymphocytes, AID initiates antibody variable (V) exon somatic hypermutation (SHM) for affinity maturation in germinal centers (GCs) and IgH switch (S) region DNA breaks (DSBs) for classswitch recombination (CSR). To resolve long-standing questions, we have developed an in vivo assay to study AID targeting of passenger sequences replacing a V exon. First, we find AID targets SHM hotspots within V exon and S region passengers at similar frequencies and that the normal SHM process frequently generates deletions, indicating that SHM and CSR employ the same mechanism. Second, AID mutates targets in diverse non-Ig passengers in GC B cells at levels similar to those of V exons, definitively establishing the V exon location as ''privileged'' for SHM. Finally, Peyer's patch GC B cells generate a reservoir of V exons that are highly mutated before selection for affinity maturation. We discuss the implications of these findings for harnessing antibody diversification mechanisms.
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In Brief
An in vivo passenger assay elucidates the role of DNA substrate sequences in AIDinitiated antibody diversification. Gutassociated B lymphocytes provide a reservoir of highly diversified and unselected antibodies.
INTRODUCTION
Antibodies are the secreted form of B cell antigen receptors (BCRs), the basic subunit of which is a pair of identical immunoglobulin (Ig) heavy (IgH) and light (IgL) chains. N-terminal regions of IgH and IgL chains provide the antigen-binding variable (''V'') region of antibodies. Ig V regions are encoded by exons (''V exons'') assembled by V(D)J recombination during bone marrow B cell development. V(D)J recombination creates diverse antibody repertoires by assembling multitudes of different germline V, D, and J combinations and by diversifying junctions between these segments through nucleotide deletions and insertions . V exons contain three highly variable domains termed complementarity-determining regions (CDRs), which encode antigen-contact sites and determine binding specificity (Di Noia and Neuberger, 2007) . CDR1 and CDR2 are encoded by germline V segments, whereas CDR3 is encoded by V(D)J junctional regions and therefore has the greatest diversity (Hwang et al., 2015) . Conserved framework regions (FWRs) between CDRs impart antibody structure. Due to junctional diversity, about two-thirds of V exons are assembled out of frame and do not encode proteins. These ''non-productive'' V exons are often present in B cells in which the other IgH (and/or IgL) locus is productively rearranged and supports development (Mostoslavsky et al., 2004) .
The mouse expresses different antibody classes determined by expressed IgH constant regions exons (C H s). The first developmentally expressed C H (Cm) generates primary B cells expressing IgM. Newly generated IgM-expressing B cells migrate to peripheral lymphoid organs, where, upon antigen activation, they further diversify primary antibody V exon repertoires by somatic hypermutation (SHM) and change expressed C H antibody effector functions via IgH class-switch recombination (CSR) (Hwang et al., 2015) . SHM occurs in response to antigen-dependent B cell activation in specialized lymphoid structures termed germinal centers (GCs) (Victora and Nussenzweig, 2012) . SHM mainly introduces point mutations into V exons (Di Noia and Neuberger, 2007) . GC B cells with SHMs that result in increased BCR antigen-binding affinity are positively selected, leading to affinity maturation, and those that decrease BCR affinity or cause loss of BCR expression are negatively selected (Di Noia and Neuberger, 2007; Victora and Nussenzweig, 2012) . IgH CSR occurs within or outside GCs and can be activated in cultured IgM-expressing primary B cells (Stavnezer et al., 2008) . During CSR, DNA double-strand breaks (DSBs) are introduced into long, repetitive switch (S) regions that precede Cm (Sm) and each downstream C H . Joining a donor Sm DSB to a downstream acceptor S region DSB mediates CSR to IgG, IgE, or IgA (Hwang et al., 2015) .
Both V exon SHM and IgH CSR are initiated by activationinduced cytidine deaminase (AID) (Muramatsu et al., 2000) , an enzyme that deaminates cytosines (C) to uridines (U) in singlestranded DNA. AID is targeted transcriptionally to V exons and S regions, where it acts on both DNA strands ).
Co-opted base excision repair (BER) or mismatch repair (MMR) factors convert AID-initiated lesions into mutational or DSB outcomes (Di Noia and Neuberger, 2007; Peled et al., 2008) . Uridine/ guanine (U/G) mismatches, which are the result of AID activity, are converted to transition or transversion mutations at initiating C/G residues by replication over uracils or over an abasic site upon uracil removal by BER (Di Noia and Neuberger, 2007) . MMR also generates transition or transversion mutations and extends SHM to flanking adenine/thymidine (A/T) residues by error prone DNA polymerase activity following excision of DNA patches around AID-generated uracils (Peled et al., 2008) . DSBs can be generated by BER in the form of adjacent nicks on both DNA strands or by MMR in the form of overlapping gaps (Saribasak and Gearhart, 2012; Chahwan et al., 2012) . AID preferentially deaminates cytidines in short RGYW (R = A/G, Y = C/T, W = A/T) or related motifs (Liu and Schatz, 2009; Hackney et al., 2009 ). Compared to the genome, such motifs are mildly enriched in certain V exons (Hackney et al., 2009 ). AGCT, a canonical RGYW motif, occurs at high density in the core of long, highly repetitive mammalian S regions, where its palindromic sequence provides AID substrates on both DNA strands (Han et al., 2011; Zarrin et al., 2004) . However, AID-targeting patterns on core S regions have not been measured due to the repetitive S region nature.
While transcription targets AID to different S regions , mechanisms that differentially target AID to sequences within a V exon or between V exons and S regions have remained enigmatic. AID targets both productive and non-productive V exons during SHM at high frequency (10 À3 mutations per base pair) (Odegard and Schatz, 2006) . Within V exons, SHMs are focused at RGYW motifs in CDRs of both productive and nonproductive alleles (Di Noia and Neuberger, 2007; Dö rner et al., 1997; Betz et al., 1993a Betz et al., , 1993b Wei et al., 2015) . RGYW motifs do not appear sufficient for targeting, since identical motifs mutate less frequently in FWRs (Dö rner et al., 1997; Wei et al., 2015) . In this regard, non-Ig sequences driven by Ig promoters and enhancers in transgenes can, in some cases, undergo substantial SHM (Yé lamos et al., 1995) . However, as such transgene results are variable and could reflect influences of integration site and copy number, they have not generally been considered to represent normal SHM processes (Yang and Schatz, 2007; Maul and Gearhart, 2010a) . Thus, the question of what mechanisms enable high AID targeting within V exons and within CDRs, in particular, has remained an enigma. Another AID-targeting enigma comes from findings that B cells or B cell lines activated in culture to undergo robust CSR have not been found to undergo SHM of adjacent, transcribed V exons (Nagaoka et al., 2002; Maul et al., 2014; Liu and Schatz, 2009) . Such findings led to the conclusion that differential mechanisms target AID to V exons versus S regions (Maul and Gearhart, 2010b; Storb, 2014) . While such mechanisms have been elusive, one postulate is that these activities involve differential activation of CSR versus SHM factors by AID (Muramatsu et al., 2007) . V exon SHM is considered to predominantly involve point mutations (Di Noia and Neuberger, 2007) and rarely lead to DSBs (Betz et al., 1993a) . Estimates of the frequency of V exon DSBs have been highly variable, likely due to the limited number of sequences analyzed (Goossens et al., 1998 , Betz et al., 1993a , 1993b Bross et al., 2000; Briney et al., 2012) . Thus, the question of whether AID specifically mediates point mutation during SHM and DSBs during CSR via distinct mechanisms has remained unresolved. Correspondingly, whether or not most V exon DSBs are directly linked to AID-initiated SHM remains an important question, given that deletions (and related insertions) can contribute to antibody specificity, for example in certain extensively mutated anti-HIV-1 broadly neutralizing antibodies (bnAb) (Wu et al., 2011; Mascola and Haynes, 2013; Kepler et al., 2014) .
Intestinal Peyer's patch (PP) GCs are chronically present in mice in the absence of specific immunization due to continual stimulation by commensals and gut antigens (Casola et al., 2004) . Correspondingly, PP GC B cells with V l exon SHMs are found robustly in BCR-deficient mice that express the Epstein Barr Virus protein LMP2a as a BCR signaling surrogate, indicating that SHM occurs in PP GC B cells in the absence of BCR engagement with antigen (Casola et al., 2004) . In this regard, intestinal B cell development and primary antibody diversification occurs in sheep, cattle, pigs, chicken, and rabbits (Lanning and Knight, 2005) and has also been implicated in the mouse (Wesemann et al., 2013) . Thus, it is conceivable that mouse PP GCs, beyond initiating antigen-specific responses, may also undergo SHM via antigen-independent stimulation to further expand primary BCR repertoires (Lanning and Knight, 2005; Casola et al., 2004) . However, the degree to which SHMs are selected by specific antigens in V exon repertoires of PP GC B cells that express a functional BCR has not been addressed.
To elucidate roles of V(D)J exon and S region sequences in AID-targeting and DSB versus mutational outcomes in mouse GC B and CSR-activated B cells, we developed an efficient approach to measure AID activity on a fixed ''productive'' IgH V(D)J exon allele, versus an array of test sequences driven by the same promoter on the other ''passenger'' allele. This approach has provided unanticipated insight into long-standing questions regarding AID targeting and outcome during SHM and CSR.
RESULTS

A V(D)J Replacement Passenger Allele System
We developed an efficient V(D)J passenger allele system to test the influence of substrate sequences on AID targeting and the outcome of such activity in mouse GC B cells or CSRactivated cultured B cells (Figures 1A and S1A) . For this approach, we generated an embryonic stem (ES) cell line with a productive pre-assembled V(D)J allele encoding the IgH V region of the 4-hydroxy-3-nitrophenylacetyl (NP)-binding B1-8 antibody (VB1-8) inserted in place of the four IgH J H segments (Sonoda et al., 1997) . On the other ''passenger'' IgH allele of these ''VB1-8'' ES cells, we inserted a puromycin-resistance cassette in place of the four J H s. To generate VB1-8 ES cells with different test passenger sequences, we replaced the inserted puromycin-resistance cassette with a ''passenger'' cassette, which consisted of a VB1-8 promoter and leader sequence containing a translation termination codon, followed by test sequences ( Figure 1A, bottom) . Thus, as the passenger test sequences cannot encode proteins, their SHM patterns are not biased by antigen-specific B cell selection forces. VB1-8/ passenger ES clones are used for RAG-2-deficient blastocyst complementation (''RDBC;' ' Chen et al., 1993) to generate chimeric mice in which all peripheral lymphocytes are derived from the injected ES cells ( Figure 1A, top) . We induce SHM in splenic GC B cells of VB1-8/passenger chimeras by short-term immunization (10 days) with NP-chicken gamma globulin (NP-CGG) or other immunogens to activate GC formation in the absence of appreciable antigen-specific B cell selection (Weiss et al., 1992) . Following immunization, we purify GC B cells from spleens and PP of individual RDBC chimeras and amplify their productive VB1-8 and the passenger allele sequences via allele-specific primers, sequence the products via next-generation high-throughput sequencing, and assay them for SHMs (Figure 1A , bottom; Figure S1B ).
Mutation Profiles of Productive and Passenger VB1-8 Alleles in Splenic GC B Cells
To validate the RDBC-based VB1-8/passenger approach, we assayed a bona fide VB1-8 sequence as a passenger ( Figure 1A , bottom). Given the essentially identical sequence and transcription control elements, we expected a similar frequency and pattern of SHMs in productive and passenger alleles of splenic GC B cells under non-selective immunization conditions. For analysis, we compared mutations per sequence in productive and passenger alleles from six different chimeras by breaking them into six different mutation strata, ranging from 0 to 31-40 mutations/sequence and using pie charts to visualize overall SHM levels for each mouse ( Figures 1B and S1C ). Both productive and passenger VB1-8 alleles were mutated substantially in splenic GC B cells ( Figure 1B , top), with levels far above background (Figures S1D and S1E; Table S1 ). While overall SHM levels varied between different chimeras, productive and passenger VB1-8 alleles in splenic GC B cells of a given chimera had very similar SHM levels (Figure 1B, top; Figure S1F, left) . Moreover, productive and passenger VB1-8 alleles in GC B cells from given chimeras had remarkably similar distributions of sequences across the six tested SHM strata (Figure 1B, top) .
Kinetic Analysis of Hotspot Mutations with Increasing Mutation Frequency
One of our major goals was to test for AID target hotspots in various passenger sequences by assaying for them in sequences with low to high mutation levels. In this regard, duplicate mutations that arise from independent targeting events at hotspots when mutation levels are low may be difficult to distinguish from PCR repeats and, therefore, difficult to capture by standard SHM analyses that exclude duplicates (e.g., Rada et al., 2004 See also Figure S1 and Table S1 .
strategy that includes duplicates, but controls for PCR repeats by analyzing 5 to 6 independent mouse replicates for each experiment and then averaging mutation frequency of each nucleotide across replicates. In addition, comparing the mutation pattern of sequences in low to high strata allowed us to visualize hotspot emergence and ongoing accumulation and thus served as a surrogate SHM kinetic analysis. For ease of presentation, we present such ''kinetic'' analyses for productive and passenger alleles in three representative bins ( Figure 2A ). The stratification of sequences into narrower bins gives similar results and conclusions ( Figure S2A , left). Combined analyses of sequence reads revealed three robust hotspots in both productive and passenger VB1-8 alleles, including the two C nucleotides on opposite DNA strands of the AGCT motif in CDR3 (positions 454 and 455) and a C in an RGYW (AGCA) motif in CDR2 (position 337) ( Figure S2B , top). These hotspots were apparent at low SHM levels (1-2 mutations/sequence) and further accumulated in sequences with intermediate (3-10 mutations/sequence) and high (11-30 mutations/sequence) SHM levels. In the latter, they were mutated in 40%-60% of sequences ( Figure 2A ). AGCT motifs in FWR1 and FW3, and certain RGYW motifs in CDR2 and CDR3, were lower level hotspots in both productive and passenger alleles, which was evident at intermediate mutation levels and more so in highly mutated sequences, reaching mutation in 20%-40% of sequences ( Figure 2A ). Within all productive and passenger sequences with high SHM levels, AGCT and RGYW motifs contributed the most residues with mutations well above background; those above background in non-RGYW motifs tended to occur adjacent to CDRs, where they may have, in part, resulted from SHM spreading from initiating G/C base pairs (bp) (Figure 2A) . Finally, the SHM frequency at each base pair of the productive allele was highly correlated with that of the passenger allele at each strata (Pearson correlation, r = 0.75-0.87) ( Figure S2C ). Overall, these findings support a ''hierarchical'' SHM process by which mutations are targeted preferentially to a few preferred CDR hotspot motifs, followed by accumulation of mutations in other AID target motifs sites and eventually in non-RGYW sequences that in part represent SHM spreading to other sites.
Peyer's Patches GC B Cells Contain Highly Mutated, but Unselected, BCR Repertoire We also examined the VB1-8 productive and passenger alleles in purified PP GC B cells from the same short-term immunized chimeras described above. Again, productive and passenger VB1-8 alleles in PP GC B cells of a given chimera had very similar overall SHM levels (Figures 1B, middle; Figure S1F , left). A major difference between SHM of productive and passenger VB1-8 sequences between splenic and PP GC B cells was that the frequency of SHMs on each was substantially higher in PP GC B cells than in splenic B cells (Figure 1B, bottom) . PP GC B cells also had a significantly greater percentage of highly mutated sequences (>20 mutations per sequence) than did splenic GC B cells ( Figure S1F, right) . Notably, despite having accumulated higher levels of SHMs, PP GC B cells exhibited very similar SHM patterns to those of splenic GC B cells on both productive and passenger alleles (Figures 2B and S2A, right; Figure S2B, bottom) . In particular, productive and passenger alleles in PP GC B cells had the same major and lower level hotspots (Figure 2B) with the only minor difference being a slight dampening of the more major hotspot levels on passenger versus productive allele sequences ( Figure 2B ), which may reflect loss of some via AID-initiated deletions (see below). Nevertheless, in PP GC B cells there were high correlations between the mutation frequencies at each base pair across each strata when comparing productive alleles to the passenger alleles (Pearson correlation, r = 0.71-0.85) (Figure S2D ), or when comparing the productive allele on PP GC B cells to the productive allele in splenic GC B cells (Pearson correlation, r = 0.80-0.90) ( Figure S2E ). Thus, in both splenic and PP GC B cells, SHM patterns reflect preferred sites of AID activity on the VB1-8 sequence rather than selection for a specific response. PP GC B cells of four unimmunized mice showed similar hotspots and highly correlated SHM profiles (Figures S1C , S2F, and S2G). These findings suggest that the BCR repertoire of PP GC B cells may reflect SHM activity on a germline V(D)J repertoire in the absence of antigen selection.
Regions that Are Highly Targeted for SHM Are Also Highly Targeted for DSBs We found deletions on average in about 8% of splenic and 19% of PP GC B cell mutated passenger allele sequences, but only in about 2% of the corresponding productive sequences (Figures 3A and 3B; Table S2A ). Given that VB1-8 passenger and productive alleles accumulated SHMs similarly, the relative absence of deletions in productive alleles likely represents negative cellular selection against B cells with BCR-inactivating deletions. We also did similar analysis of unique (excluding duplicates) sequences and reached the same conclusions (Figures S3A and  S3B ; Table S2B ). For both splenic and PP GC passenger VB1-8 sequences, deletion frequency was directly related to SHM frequency as sequences with higher levels of mutations had higher levels of deletions ( Figures S3C and S3D) . In this regard, many unique deletions in passenger VB1-8 alleles ( Figures 3C and  3D ) (and productive alleles; Figures S3E and S3F ) had endpoints that occurred in and around VB1-8 CDR sequences, the sites that harbor the highest SHM levels (Figure 2 ). The location of deletions endpoints versus SHMs along VB1-8 passenger sequences was highly correlated for both splenic GC B cell sequences ( Figure 3E ) and PP GC B cell sequences ( Figure 3F ). Thus, AID targeting for SHMs in VB1-8 frequently generated DSBs that were the precursors for deletions. Finally, we found very low levels of insertions in the assayed VB1-8 productive and passenger allele sequences ( Figures S3G and S3H ).
Non-Ig Sequences Target as Robust SHM as V Exons
To address the question of whether high-level SHM targeting is unique to V exon CDR sequences, we assayed SHM activity on two non-Ig passenger allele substrates, an Escherichia coli gpt gene (Figures 4 and S4 ) and a human b-globin gene ( Figures  5 and S5) , and compared SHM frequency on each passenger to that of its corresponding productive VB1-8 allele. These non-Ig sequence passengers were matched to the VB1-8 sequence in size (360 bp) and also contained similar densities of AID-targeting motifs ( SHM and have remarkably similar frequency distributions of mutations per sequence and mutation frequencies to the productive V(D)J allele ( Figures 4A, 4B, 5A , 5B, S4A, and S5A). The mutation frequency of each type of base substitution also was similar between non-Ig passengers and their corresponding VB1-8-productive alleles (Figure S4B , top; Figure S5B , top). As for VB1-8 passengers, non-Ig passengers were more highly mutated in PP GC B cells (Figures S4C and S5C ). SHM profiles of passenger gpt and b-globin sequences show that hotspots occurred mainly on RGYW motifs, including AGCTs, and that the same hotspots were identified in non-Ig passenger sequences from splenic and PP GC B cells ( Figures 4C, 4D , 5C, and 5D). SHM of the most robust hotspots in the non-Ig passengers (e.g., nucleotides G of AGCT motif at position 253 in gpt and in position 292 in b-globin) showed mutation frequencies comparable to those of VB1-8 AGCTs in CDRs (e.g., nucleotides G at position 454 or 232) ( Figures 4C, 4D , 5C, 5D, and S4B, bottom; Figure S5B See also Figure S3 and Table S2. strata ( Figures S4D, S4E , S5D, and S5E). As for VB1-8 passengers, SHM patterns in splenic GC B cells and PP GC B cell sequence were very similar, despite the latter accumulating higher levels of mutations ( Figures 4C, 4D , 5C, 5D, S4D, S4E, S5D, and S5E). Also, like the VB1-8 passenger, gpt and b-globin passenger sequences underwent substantial levels of deletions ( Figures S4F, S4G , S5F, and S5G), with endpoints highly correlated with the location of SHMs ( Figures  S4H, S4I , S5H, and S5I).
SHM Profile of S Regions in GC B Cells
Analyses of SHM patterns of core mouse S regions have been hindered by their highly repetitive sequence (Rouaud et al., 2013) . We circumvented this limitation by using a 756-bp truncation of Sm, which includes 426 bp of the Sm core as a passenger, in both direct and inverted orientations (''cSm'' and ''inSm,'' respectively; Figure 6A ). For analyses, the cSm and inSm passengers were sequenced by Sanger method, since we could not optimize high-throughput sequencing through these highly repetitive sequences. Given the more limited number of reads obtained by this approach, we focused on SHM patterns, by pooling reads from six mice and plotting for unique sequences the total number of mutations at each base pair. For both cSm and inSm passengers, each of the densely packed S region AGCT motifs are SHM hotspots in both PP GC B cells ( Figures 6B, S6A , and S6B) and splenic GC B cells ( Figure S6C ). The symmetrical AID targeting of SHMs of cytidines within AGCT palindromes in both transcriptional directions likely facilitates S region DSBs as proposed (Di Noia and Neuberger, 2007) . Further supporting the importance of the AGCTs to DSB formation, the great majority of deletions in passenger cSm and inSm sequences map to regions of high AGCT density which occur on opposite ends of the cSm and inSm passenger sequences ( Figures 6C, S6D, and S6E) . Finally, intervening G/C-rich stretches between AGCT hotspots are rarely SHM targets in the passenger sequences ( Figures  6B and S6C ). As these G/C stretches are highly conserved in mammalian S regions, our findings suggest that they may provide functions other than serving as targets for AID-initiated lesions.
SHM of V Region in B Cells Activated in Culture
While S regions are AID targets in both GC and CSR-activated B cells in culture, V exons reportedly are targeted by AID only in GC B cells (Storb, 2014; Nagaoka et al., 2002; Maul et al., 2014) , leading to the lingering question of how AID is targeted to S regions, but not adjacent IgH V exons, given that both are transcribed (Storb, 2014) . We re-evaluated this notion, now with the insight that SHMs of VB1-8 in GC B cell sequences with low SHM levels concentrate in two CDR3 AGCT hotspots ( aCD40 plus IL-4 to induce CSR to Sg1 and Sε ( Figures 7A, 7B , and S7A-S7C). However, examination of SHM at VB1-8 hotspot nucleotides 454 and 455 of productive and passenger VB1-8 alleles in CSR-activated B cells reveals that they undergo readily detectable and similar levels of SHM ( Figure 7B ) and deletions ( Figures S7D-S7H ). Indeed, comparison of SHM profiles of productive and passenger VB1-8 alleles of CSR-activated B cells with those of GC B cell sequences with similarly low SHM levels (1-2 mutations/sequence), reveals highly similar profiles and extent of hotspot nucleotide 454 and 455 mutation ( Figures 7C  and 7D ).
To compare mutation frequencies of hotspots in VB1-8 to those in S regions, we assayed day 4 CSR-activated B cells that harbored a productive VB1-8 and a passenger Sm. For these analyses, we sequenced a portion of passenger cSm amenable to high-throughput analysis (''Pas 5 0 Sm'') and also the same portion of the endogenous Sm (''Endo 5 0 Sm'') ( Figure 7E ). The overall mutation frequency of the Pas 5 0 Sm was much greater (more than 7-fold) than that of the productive VB1-8 exon (Figures 7F, left; Figures S7I-S7K) . However, comparison of the SHM level of VB1-8 nucleotide 455 to that of a representative S region AGCT hotspot at nucleotide 353 revealed them to be quite similar ( Figure 7F, right) . Thus, the increased frequency of overall SHM of Pas 5
0 Sm compared to that of VB1-8 is generated by the much larger number of AGCT (and related) hotspots in Pas 5 0 Sm, rather than increased AID-activity at a given hotspot (Figure 7G) . Notably, the endogenous 5 0 Sm sequence undergoes SHM at AGCT hotspots at somewhat increased levels (approximately 3-fold) compared to that of AGCT motifs in the Pas 5 0 Sm (Figure 7F , right; Figure 7G ). This increase could result from different transcriptional promoters and/or effects of having an adjacent full-length S region that could influence AID recruitment via transcription-associated mechanisms and/or by promoting longer stable R loops that increase AID access. Finally, cSm Figures S7Q and S7R ). As Sanger sequencing in GC B cells indicated that SHM frequency 5 0 Sm AGCT hotspots were similar to that of such hotspots across core Sm (Figure S6A ), we concluded that relatively low SHM levels of individual AGCT motifs in cSm collectively are sufficient to drive CSR.
DISCUSSION
We describe a rapid passenger allele approach to test intrinsic capacity and preferences of AID to induce SHMs and DSBs within test sequences that replace a non-productive IgH V exon. A key feature of the approach is lack of cellular selection for or against mutations and deletions, enabling insights into roles of substrate sequences in AID-targeting. In this regard, the assay uses short immunization protocols that do not activate affinity maturation; thus, SHM patterns on identical productive and passenger V exon sequences in GC B cells are remarkably similar, both in extent and detail. This assay feature allows use of the same productive allele to standardize overall SHM experienced by different passengers in different experiments. Additional assay innovations include retaining all recovered sequences for analysis and relying on multiple biological replicates to validate conclusions, allowing detection of AID hotspots even at low overall SHM levels, such as those early in an immune response or the previously unappreciated V exon SHMs in cultured CSR-activated B cells. Also, by dividing recovered sequences into mutational strata, we can estimate relative mutational kinetics at which SHMs of a particular nucleotide appear, revealing early and late hotspots, as well as ''spreading'' of SHMs from CDR hotspots to adjacent regions. This overall approach allowed us to address long-standing questions in the SHM and CSR field (see below). Finally, many of these powerful assay features could be extended to dissect contributions of sequence-intrinsic AID targeting to affinity maturation and antibody responses by using an antigen -specific productive V(D)J exon and a matched passenger V(D)J exons in the context of longer term immunizations.
Mechanisms that Target SHM Activity
We addressed the long-standing question of whether V exon sequences are required to recruit high-level SHM activity. Our studies reveal that single-copy bacterial gpt and human b-globin sequences in the endogenous V exon location have overall SHM frequencies similar to V exons and that some of their AID target motifs mutate at similar frequencies as the same motifs in V exon CDR sequences. These findings prove that high level SHM targeting in GC B cells is not specific to V exons, or even CDR sequences; establishing definitively that the V exon location is privileged for SHM. Mechanisms that make V exon location privileged for AID targeting may involve linked enhancers (Odegard and Schatz, 2006; Buerstedde et al., 2014; Rouaud et al., 2013) , adjacent AID recruitment motifs (Storb, 2014) , or transcriptional-related mechanisms, such as convergent sense/antisense transcription (Meng et al., 2014) . SHM versus CSR specific AID-targeting factors were hypothesized based on the notion that V exons do not undergo SHM in CSR-activated B cells (Muramatsu et al., 2007) ; however, our finding that V exons are targeted for SHM in CSR-activated B cells obviates a strict requirement for such factors (see below).
It has generally been thought that CDRs are highly evolved to target high SHM levels (e.g., Wei et al., 2015) . Consistent with this notion, AGCT or AGCA motifs in the V(D)J exon CDRs are hotspots, while the same motifs in FWRs are not (Figure 2) . However, we found similar examples in the bacterial gpt sequence, where one AGCT (position 253) was as strong a hotspot as those in VB1-8 CDRs, while another was not (position 228) ( Figures 4C  and 4D ). Likewise, in the b-globin sequence, AACC at position 193 was a major hotspot, but the identical motif at position 262 was not ( Figures 5C and 5D) . Thus, the elements that can enhance SHM at CDRs and/or suppress SHM at FWRs are not specialized to V exons or to CDR sequences. Such relatively recurrent hotspot sequence combinations are likely evolutionarily selected for in CDRs and against in FWRs. In ongoing studies, we are using the passenger system to test additional sequence combinations flanking AGCT hotspots within otherwise randomized synthetic sequences to ultimately elucidate sequences that define an AID hotspot in the V exon location.
SHMs and DSBs Are Targeted by the Same Mechanism
We now show that deletions occur frequently on highly mutated V(D)J exons as part of a normal SHM process. In this regard, we demonstrate a clear and direct relationship between SHM activity and DSB activity on a V exon, with the highest density and the majority of deletion endpoints focused at locations of highest level SHM (e.g., at AGCTs within CDR sequences). In addition, See also Figure S7 .
we found that this same relationship holds for non-Ig passenger sequences. Taken together, our findings reveal that DSB generation within V(D)J exons is a common and normal outcome of SHM activity. These findings answer a long-standing question in the vaccine field regarding how bnAbs with Ig chains encoded by V exons harboring deletions arise by showing that specialized mechanisms are not necessary. Our findings that highly mutated PP GC B cells contain abundant V exon deletions offers the potential of developing new strategies to elicit such antibodies (see below).
Features that Optimize S Region Sequences for CSR By using a passenger Sm region, we are able to view in-depth the SHM and DSB (deletion) pattern of core S regions. Mammalian Sm contained large numbers of densely packed repeats closely related to the sequence GGGGTGAGCT. Strikingly, within such core Sm repeats, Cs on both strands of the canonical AGCT hotspot duplexes were robustly targeted in both transcriptional orientations in GC B cells. In this regard, DSBs/deletions in passenger core Sm were highly enriched in regions of high AGCT density, independent of transcriptional orientation, providing direct support for the model that the high density of these palindromic targets allows generation of closely spaced AID-initiated lesions on both strands that then promote DSBs (Di Noia and Neuberger, 2007) . Notably, however, we found little or no targeting of Cs in Sm passengers that occurred opposite the conserved template strand Sm repeat G-stretches, even if Sm transcriptional orientation was reversed. This latter finding is consistent with adjunct functions, perhaps in AID recruitment via R-loops (Shinkura et al., 2003) , RNA-mediated mechanisms (Zheng et al., 2015) , and/or potential roles in S region synapsis (Maizels and Gray, 2013) . Prior studies concluded that V exons are not SHM targets in B cell activated in culture. Consistent with this notion, we found the passenger Sm had an approximately 7-fold greater overall mutation frequency than the V exon in CSR-activated B cells. However, AGCT hotspot motifs in V exons and S region passengers were targeted at similar levels in these cells with the increased overall SHM frequency of the S region passenger reflecting a greater number of AGCT hotpots. Indeed, endogenous Sm region AGCT motifs are targeted only about 2-fold more frequently than AGCT hotspots in passenger V exons. Notably, the pattern and extent of V exon hotspot mutations in CSR-activated B cells was similar to that of GC B cells early in the process of SHM accumulation. Thus, we suggest that SHM is limited in CSR-activated B cells because they have not been exposed to sufficient AID-activity, due to AID levels, length of exposure, or both. Still, Sm passengers, while having similarly low-level SHM at AID hotspot motifs as GC B cells early in the process, were targeted for sufficient DSBs to promote relatively robust joining to downstream S region sequences in a CSR-like process. Thus, the great abundance of palindromic AGCT hotspots make S regions highly sensitive substrates for generating CSR-initiating DSBs at relatively low-level AID exposure. Accordingly, the limited number of highly targeted AGCT motifs in the V exon results in fewer deletions/DSBs in the V exon compared to the S region. Based on our findings, we propose that ability of S regions to undergo DSBs with limited AID exposure evolved to allow efficient IgH CSR, without generating substantial SHM of adjacent V exons that could affect antibody affinity or specificity.
Implications for Generation of Highly Mutated
Antibodies during an Immune Response Microbial antigens promote formation of PP GCs and IgL V exon SHM without immunization (Gonzá lez-Ferná ndez and Milstein, 1993) and even in the absence of antigen recognition via IgH or IgL chains in the context of a BCR (Casola et al., 2004) . The latter studies led to the hypothesis that chronic activation of PP GC B cells expands primary V(D)J recombination-generated antibody repertoires via extensive SHM in the absence of antigenic engagement of BCR (Casola et al., 2004) . Our studies support this hypothesis by showing that productive and passenger IgH VB1-8 alleles in PP GC B cells undergo similarly high levels and specific patterns of SHMs, with the same set of major hotspots that reflect preferred AID SHM targets. Indeed, under short-term immunization conditions, SHM patterns of VB1-8 productive and passenger sequences were highly similar between splenic and PP GC B cells. Moreover, each Ig or non-Ig passenger, respectively, had similar SHM and deletion patterns in splenic versus PP GC B cells, except that levels were higher in the latter. Notably, primary hotspots in PP GC B cell productive and passenger alleles become saturated at high SHM levels, with additional SHMs accumulating in secondary hotspots or non-hotspot regions, allowing further diversification that might be enhanced by primary hotspot saturation. While our current studies do not assay for theoretical contributions of endogenous IgL chains, they clearly show that PP GC B cells harbor a diverse IgH VB1-8 repertoire via high-level SHM in the absence of obvious selection. This process could generate B cell lineages that provide V exons with high levels of mutations and deletions as substrates for further mutation and selection via antigen-specific responses, providing greater diversity for additional mutational and selective forces. Our findings, coupled with prior findings (Casola et al., 2004) , raise the possibility of tapping the highly mutated PP GC B cell antibody reservoir as an approach to elicit anti-HIV1 bnAbs or other antibodies with abundant SHMs and/or deletions.
EXPERIMENTAL PROCEDURES
Generation of Targeted ES Cells
An ES cell line containing a VB1-8-productive allele (Sonoda et al., 1997 ) and a puromycin cassette in place of the V(D)J exon on the other allele was generated. ES cell lines containing passenger alleles were generated by replacing the puromycin cassette with the respective passenger sequences (see the Supplemental Experimental Procedures for details). Chimeric mice were generated by RAG-2 blastocyst complementation (Chen et al., 1993) .
Assays for SHM GC B cells from spleen and PP were collected from 8-to 12-week-old mice immunized with NP-CGG (N-5055A; Biosearch Technologies) for 10 days. GC B cells were isolated from PPs and spleens of chimeras by flow cytometry sorting of cells that are B220+ and Peanut Agglutinin (PNA) hi. B220+ PNA lo cells were also collected during each sort and (along with ES cell DNA) served as negative controls for SHM. For SHM analysis of CSR-activated B cells in vitro, naive B cells collected from the spleen of 6-to 8-week-old mice were stimulated with aCD40 and IL4 for 4 days (see the Supplemental Experimental Procedures for details).
PCR and Sequencing
The productive and passenger alleles were amplified in separate PCR reactions using allele-specific primers. The products were sequenced by 2 3 250 bp Illumina MiSeq high-throughput sequencing (Illumina) or Sanger sequencing systems, where indicated in the text. For Illumina high-throughput sequencing, sequencing adapters and barcodes were added to the end of DNA fragments by a second round of PCR (see the Supplemental Experimental Procedures for details).
Data Analysis
A custom pipeline was used to process the sequencing data and to call mutations. To compare the location of deletion endpoints versus SHMs along passenger sequences, we measured the frequency of each within 10-bp bins and calculated the Pearson correlation (r) between deletion endpoint frequency and mutation frequency (see the Supplemental Experimental Procedures for details). Statistical analysis is as stated in the figure legends.
ACCESSION NUMBERS
The accession number for the next-generation sequencing data reported in this paper has been uploaded to the NCBI Sequence Read Archive: SRP061422. 
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